brain tumor

Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project

Editor’s Choice DSC-MR imaging data were collected after a preload and during a bolus injection of gadolinium contrast agent using a gradient recalled-echo-EPI sequence. Forty-nine low-grade and high-grade glioma datasets were uploaded to The Cancer Imaging Archive. Datasets included a

Fellows’ Journal Club Recap: Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas

Please check out the accompanying podcast of this blog post (discussion of this article begins at 8:30) Glioblastoma is a heterogeneous group of cancers, genetically, molecularly and characteristically on imaging studies. Prior studies have supported the relationship between tumor location

The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study)

Fellows’ Journal Club Editor’s Comment The authors performed a crossover, intraindividual comparison of 0.1-mmol/kg gadobenate with 0.1-mmol/kg gadoterate (Arm 1) and 0.05-mmol/kg gadobenate with 0.1-mmol/kg gadoterate (Arm 2). In Arm 1, a significant superiority of 0.1-mmol/kg gadobenate was demonstrated by